Expression of cell surface antigens by suppressor T cell hybridomas. I. Comparison of phenotype and function

Academic Article

Abstract

  • The phenotypic expression of cell surface markers by T cell hybridomas that elaborate suppressor factors specific for the polymers L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAY) or L-glutamic acid 50-L-tyrosine 50 (GT) has been analyzed. We found that determinants encoded by the I-J subregion of the H-2 complex were borne on the surface of these hybrid cells and on the factors they secrete, whereas I-J determinants were not expressed by the AKR thymoma fusion parent, BW5147. The level of expression of I-J determinants fluctuated widely depending upon culture conditions, but I-J products and other cell surface markers of normal T cells could be quantitatively increased, or induced to appear, by treatment of the hybridomas with chemical agents, such as dimethyl sulfoxide (DMSO) or phorbol myristate acetate (PMA). In contrast, the surface expression of the viral product gp70 was decreased by the same treatment. Using chemical induction, we typed BW5147, a group of antigen-specific suppressor T cell hybridomas, and two control hybridomas for expression of I-J, Thy-1, Lyt, and H-2K alloantigens. Also, a haplotype-specific hybridoma that produces an antigen-nonspecific factor was analyzed. The results demonstrated that BW5147 failed to express I-J or Lyt alloantigens but expressed Thy-1.1 and H-2K(k) gene products. The pattern of expression of these antigens by T cell hybridomas was very complex, but three conclusions could be drawn: 1) Good correlation exists between the expression of certain I-J determinants and the ability of T cell hybridomas to produce suppressor factor. 2) The expression of Thy-1, Lyt, or H-2K(k) determinants is variable, and no correlation was found between expression of these antigens and the ability to produce active suppressor factors. 3) I-J(d) products contributed by the AKR thymoma fusion partner are expressed by T cell hybridomas.
  • Authors

    Published In

    Author List

  • Trial J; Kapp JA; Pierce CW; Shreffler DC; Sorensen CM; Waltenbaugh C
  • Start Page

  • 565
  • End Page

  • 572
  • Volume

  • 130
  • Issue

  • 2